Skip to main content

Table 1 Demographic and histopathologic information of the bladder cancer patients and controls providing urinary samples utilized for DNA profiling using oligonucleotide array-CGH

From: Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA

Bladder Cancer Patients

ID

Gendera

Age

Stage

Grade

105 HG

M

65

pTA

G1

125 HG

F

51

pTA

G1

130 HG

M

54

pTA

G1

136 HG

M

58

pTA

G1

138 HG

F

70

pTA

G3

75 HS

M

75

pT1

G2

123 HG

M

78

pT1

G2

131 HG

M

81

pT1

G2

141 HG

M

72

pT1

G3

127 HG

M

79

pT2

G3

132 HG

M

74

pT2

G3

139 HG

M

69

pT2

G3

129 HG

M

66

pT2

G3

100 HG

M

78

pT4

G3

Controls

ID

Gender a

Age

Pool

Status

DNA 19/10

F

30

1

Healthy donor

76HS

M

83

1

No evidence of disease

79HS

F

73

1 & 2

Cystitis

111HG

M

55

1

No evidence of disease

116HG

F

61

2

Healthy donor

118HG

M

61

1 & 2

No evidence of disease

135HG

M

51

2

Healthy donor

143HG

F

71

2

Healthy donor

  1. aM, Male; F, Female.